Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Yet another life-saving drug that the FDA refused

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155444
(Total Views: 606)
Posted On: 12/29/2023 4:24:38 PM
Avatar
Posted By: Drano
Yet another life-saving drug that the FDA refused to approve (against the advice of the advisory committee). This refusal to approve certainly has resulted in deaths. But hey, we have to protect Big Pharma profits, that's a lot more important than kids dying.
What makes it even worse is that the drug is epinephrine, the active ingredient in the EpiPen, and they refused to approve an easier delivery system.
Remember how they jacked the price up of the EpiPens by something like 300% when the FDA refused to approve a generic?
Quote:

Earlier this year, the FDA had the opportunity to approve Neffy, a needle-free, low-dose intranasal epinephrine nasal spray developed by ARS Pharmaceuticals. Even though the agency had strong evidence of the product’s safety and efficacy, in a surprise move, regulators declined to clear the therapeutic for use. Instead, they requested completion of a pharmacokinetic/pharmacodynamic efficacy study assessing repeat doses of the drug, compared with repeat doses of an epinephrine injection project under allergen-induced allergic rhinitis conditions to support approval. I am aware of no independent expert who endorsed FDA’s request for additional information.
https://www.statnews.com/2023/12/29/neffy-sub...e=hs_email



(4)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us